PHASE-II STUDY ON DUP-937 (TELOXANTRONE) IN COLORECTAL-CARCINOMA - A CANADIAN-NATIONAL-CANCER-INSTITUTE CLINICAL-TRIAL GROUP-STUDY

Citation
Ja. Maroun et al., PHASE-II STUDY ON DUP-937 (TELOXANTRONE) IN COLORECTAL-CARCINOMA - A CANADIAN-NATIONAL-CANCER-INSTITUTE CLINICAL-TRIAL GROUP-STUDY, Investigational new drugs, 11(2-3), 1993, pp. 235-237
Citations number
3
Categorie Soggetti
Pharmacology & Pharmacy",Oncology
Journal title
ISSN journal
01676997
Volume
11
Issue
2-3
Year of publication
1993
Pages
235 - 237
Database
ISI
SICI code
0167-6997(1993)11:2-3<235:PSOD(I>2.0.ZU;2-E